Scope
12 employees on LinkedIn · 1 known investors
Scope Biosciences develops scopeDx, a CRISPR-Cas-based molecular diagnostic test for on-site detection of crop pathogens, offering PCR-level sensitivity with results in under an hour without a laboratory. It targets agricultural growers seeking early, pre-symptomatic disease detection to protect crop yields.
Investors · 1
Frequently asked questions
- What does Scope do?
- Scope Biosciences develops scopeDx, a CRISPR-Cas-based molecular diagnostic test for on-site detection of crop pathogens, offering PCR-level sensitivity with results in under an hour without a laboratory. It targets agricultural growers seeking early, pre-symptomatic disease detection to protect crop yields.
- Who are Scope's investors?
- Scope's investors include SHIFT Invest.